Treatment for Recurrent Ovarian Cancer—At First Relapse

Table 6

Recommendation for secondary cytoreduction based on disease free interval and number of recurrence site.

Disease free	Single site	Multiple site	Carcinomatosis
interval		no carcinomatosis
6–12 Mo	offer SC	consider SC	No SC
12–30 Mo	offer SC	offer SC	consider SC
>30 Mo	offer SC	offer SC	offer SC

DFI: disease free interval. SC: secondary cytoreduction. Chi et al. [21].